NCT01693315View on ClinicalTrials.gov

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
GlaucomaOcular HypertensionEye Disease
Interventions
DRUG

AMA0076

DRUG

Placebo

Trial Locations (6)

Unknown

Artesia Clinical Site - Site 02, Artesia

Inglewood Clinical Site - Site 03, Inglewood

Petaluma Clinical Site - Site 05, Petaluma

New Haven Clinical Site - Site 01, New Haven

Atlanta Clinical Site - Site 04, Atlanta

High Point Clinical Site - Site 06, High Point

Sponsors

Lead Sponsor

Amakem, NV
All Listed Sponsors
lead

Amakem, NV

INDUSTRY

NCT01693315 - Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma | Biotech Hunter | Biotech Hunter